|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01681 CONSUN PHARMA
Nominal 
9.260 -0.240 (-2.526%) Non-current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 14,141 | -3.369% | 14,634 | 15,127 | 15,620 | 16,121 |
| Property, plant, equip. & others | 797,581 | 7.919% | 739,056 | 746,213 | 724,633 | 675,773 |
| Land & other Lease Assets | 127,959 | 2.653% | 124,652 | 128,786 | 133,815 | 123,675 |
| Intangible Assets | 268,960 | -5.008% | 283,140 | 311,904 | 341,664 | 371,423 |
| Interests in Asso. & JCEs | 9,934 | -- | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 83,194 | 21.572% | 68,432 | 67,679 | 91,177 | 104,564 |
| 1,301,769 | 5.842% | 1,229,914 | 1,269,709 | 1,306,909 | 1,291,556 | |
Current Assets
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 289,677 | -21.088% | 367,087 | 276,080 | 243,035 | 227,374 | |
| Trade Receivables | 297,573 | 16.313% | 255,838 | 259,562 | 351,226 | 448,540 | |
| Cash & Bank Balances | 2,907,682 | 5.801% | 2,748,262 | 2,450,173 | 2,196,323 | 1,940,273 | |
| Other Current Assets | 1,056,381 | 16.484% | 906,893 | 636,856 | 265,245 | 42,510 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 4,551,313 | 6.387% | 4,278,080 | 3,622,671 | 3,055,829 | 2,658,697 | ||
Current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 75,643 | -8.971% | 83,098 | 59,891 | 66,638 | 50,889 | ||
| S-T Debt & Leases | 259,763 | -48.829% | 507,636 | 454,229 | 602,426 | 549,414 | ||
| Other Current Liabilities | 1,035,394 | 14.502% | 904,262 | 836,368 | 688,343 | 731,560 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 1,370,800 | -8.307% | 1,494,996 | 1,350,488 | 1,357,407 | 1,331,863 | |||
| Net Current Assets | 3,180,513 | 14.280% | 2,783,084 | 2,272,183 | 1,698,422 | 1,326,834 | ||
| Total Assets Less Current Liabilities | 4,482,282 | 11.694% | 4,012,998 | 3,541,892 | 3,005,331 | 2,618,390 | ||
Non-current Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 7,406 | 89.995% | 3,898 | 5,947 | 8,547 | 0 | |||
| Other Non-current Liabilities | 81,824 | -9.475% | 90,388 | 96,940 | 86,003 | 101,892 | |||
| 89,230 | -5.362% | 94,286 | 102,887 | 94,550 | 101,892 | ||||
Capital and Reserves
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 67,308 | 5.479% | 63,812 | 63,450 | 64,800 | 64,424 | ||||
| Reserves | 4,030,295 | 13.125% | 3,562,691 | 3,081,689 | 2,552,905 | 2,155,943 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 4,097,603 | 12.990% | 3,626,503 | 3,145,139 | 2,617,705 | 2,220,367 | ||||
| Non-controlling Interests | 295,449 | 1.109% | 292,209 | 293,866 | 293,076 | 296,131 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 4,393,052 | 12.104% | 3,918,712 | 3,439,005 | 2,910,781 | 2,516,498 | |||||
Commitments and Contingent Liabilities
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 532,903 | 450,758 | 482,495 | 473,870 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 30/04/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 910,458 |
| %Change | 16.051% |
| EPS / (LPS) | RMB 1.110 |
| NBV Per Share (¥) | RMB 4.824 |